Video

William Jordan, MD, National Principal Investigator, Shares His Views on the Clinical Outcomes 5-year Results From U.S. IDE Clinical Trial for Thoracic Aortic Aneurysms

Click the photo below to watch the video!

Stay in the Know

Vascular Disease Management Newsletter

News

Cardiovascular Scientific Forum

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

02/03/2026

Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...

Physician-led Collaboration...

02/03/2026

Vascular Disease Management

thrombectomy

Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology

01/27/2026

Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.

Penumbra recently launched the...

01/27/2026

Cath Lab Digest

Acquisitions

Boston Scientific Announces Agreement to Acquire Penumbra, Inc.

01/15/2026

MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...

MARLBOROUGH, Mass. and ALAMEDA,...

01/15/2026

Cath Lab Digest

Peripheral Arterial Disease

CIS and Terrebonne General Are First in Louisiana to Use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter

01/09/2026

JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...

JANUARY 8, 2026 –HOUMA, LA...

01/09/2026

Vascular Disease Management

Radiation Safety

Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection

01/08/2026

First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...

First-of-its-Kind,...

01/08/2026

Vascular Disease Management

Deep Venous Disease

Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins

01/06/2026

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...

The GORE® VIABAHN® FORTEGRA...

01/06/2026

Vascular Disease Management

Neuro Intervention

Penumbra Receives CE Mark for MIDWAY and ACCESS25 Delivery Catheters in Europe

12/19/2025

MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.

MIDWAY 43 and MIDWAY 62 delivery...

12/19/2025

Vascular Disease Management

Thrombectomy

Study Finds CAVT (Computer-Assisted Vacuum Thrombectomy) Shortens Hospital Stay and May Ease Burden on Hospital Systems

12/16/2025

The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.

The research suggests that CAVT,...

12/16/2025

Cath Lab Digest

Intravascular Imaging

Philips Agrees to Acquire SpectraWAVE Inc., Advancing Next-Generation Coronary Intravascular Imaging and Physiological Assessment With AI

12/16/2025

Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...

Acquisition of SpectraWAVE’s...

12/16/2025

Vascular Disease Management

Acute Type A Dissection

Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study

12/15/2025

The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.

The first pivotal trial implant...

12/15/2025

Vascular Disease Management

William Jordan, MD, National Principal Investigator, Shares His Views on the Clinical Outcomes 5-year Results From U.S. IDE Clinical Trial for Thoracic Aortic Aneurysms

Stay in the Know

News

HMP Global Products

Events